N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Kanthasamy, Arthi ^a   Chandramani Shivalingappa, Prashanth ^a   Jin, Huajun ^a   Anantharam, Vellareddy ^a   Kanthasamy, Anumantha ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; GLUTATHIONE; METHAMPHETAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VACUOLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NITRATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 84867786709     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/424285     Document Type: Article

References (66)

1. Krasnova I. N., Cadet J. L., Methamphetamine toxicity and messengers of death. Brain Research Reviews 2009 60 2 379 407 2-s2.0-67349212306 10.1016/j.brainresrev.2009.03.002
2. Homer B. D., Solomon T. M., Moeller R. W., Mascia A., DeRaleau L., Halkitis P. N., Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychological Bulletin 2008 134 2 301 310 2-s2.0-40849139473 10.1037/0033-2909.134.2.301
3. Ernst T., Chang L., Leonido-Yee M., Speck O., Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000 54 6 1344 1349 2-s2.0-0034724360 (Pubitemid 30174057)
4. Stephans S. E., Yamamoto B. K., Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 1994 17 3 203 209 2-s2.0-0028307821 10.1002/syn.890170310 (Pubitemid 24204347)
5. Michel P. P., Hefti F., Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. Journal of Neuroscience Research 1990 26 4 428 435 2-s2.0-0025063462 10.1002/jnr.490260405 (Pubitemid 20261989)
6. Wu C. W., Ping Y. H., Yen J. C., Chang C. Y., Wang S. F., Yeh C. L., Chi C. W., Lee H. C., Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicology and Applied Pharmacology 2007 220 3 243 251 2-s2.0-34247211016 10.1016/j.taap.2007.01.011 (Pubitemid 46627839)
7. Potula R., Hawkins B. J., Cenna J. M., Fan S., Dykstra H., Ramirez S. H., Morsey B., Brodie M. R., Persidsky Y., Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. Journal of Immunology 2010 185 5 2867 2876 2-s2.0-78049398990 10.4049/jimmunol.0903691
8. Fitzmaurice P. S., Tong J., Yazdanpanah M., Liu P. P., Kalasinsky K. S., Kish S. J., Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. Journal of Pharmacology and Experimental Therapeutics 2006 319 2 703 709 2-s2.0-33751189188 10.1124/jpet.106.109173
9. Yamamoto B. K., Zhu W., The effects of methamphetamine on the production of free radicals and oxidative stress. Journal of Pharmacology and Experimental Therapeutics 1998 287 1 107 114 2-s2.0-0032462195 (Pubitemid 29140192)
10. Zainal T. A., Weindruch R., Szweda L. I., Oberley T. D., Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload. Free Radical Biology and Medicine 1999 26 9-10 1181 1193 2-s2.0-0032982507 10.1016/S0891-5849(98)00312-8 (Pubitemid 29262704)
11. Page S., Fischer C., Baumgartner B., Haas M., Kreusel U., Loidl G., Hayn M., Ziegler-Heitbrock H. W. L., Neumeier D., Brand K., 4-Hydroxynonenal prevents NF- κ B activation and tumor necrosis factor expression by inhibiting phosphorylation and subsequent proteolysis. Journal of Biological Chemistry 1999 274 17 11611 11618 2-s2.0-0033597234 10.1074/jbc.274.17.11611 (Pubitemid 29197818)
12. Toyokuni S., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H., Stadtman E. R., Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proceedings of the National Academy of Sciences of the United States of America 1994 91 7 2616 2620 2-s2.0-0028223268 (Pubitemid 24139398)
13. Tsai L., Szweda P. A., Vinogradova O., Szweda L. I., Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proceedings of the National Academy of Sciences of the United States of America 1998 95 14 7975 7980 2-s2.0-0032493431 10.1073/pnas.95.14.7975 (Pubitemid 28326051)
14. Doorn J. A., Petersen D. R., Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chemical Research in Toxicology 2002 15 11 1445 1450 2-s2.0-0036852609 10.1021/tx025590o (Pubitemid 35364906)
15. Spitz D. R., Sullivan S. J., Malcolm R. R., Roberts R. J., Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radical Biology and Medicine 1991 11 4 415 423 2-s2.0-0026056595 10.1016/0891-5849(91) 90159-Z
16. Ara J., Przedborski S., Naini A. B., Jackson-Lewis V., Trifiletti R. R., Horwitz J., Ischiropoulos H., Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7659 7663 2-s2.0-0032560486 10.1073/pnas.95.13.7659 (Pubitemid 28293309)
17. 2 peptide. Proceedings of the National Academy of Sciences of the United States of America 1996 93 8 3377 3382 2-s2.0-0029983162
18. Hanafy K. A., Krumenacker J. S., Murad F., NO, nitrotyrosine, and cyclic GMP in signal transduction. Medical Science Monitor 2001 7 4 801 819 2-s2.0-0034928756 (Pubitemid 32691766)
19. Metzen E., Zhou J., Jelkmann W., Fandrey J., Brüne B., Nitric oxide impairs normoxic degradation of HIF-1 α by inhibition of prolyl hydroxylases. Molecular Biology of the Cell 2003 14 8 3470 3481 2-s2.0-0042469448 10.1091/mbc.E02-12-0791 (Pubitemid 37013142)
20. Willard B. B., Ruse C. I., Keightley J. A., Bond M., Kinter M., Site-specific quantitation of protein nitration using liquid chromatography/tandem mass spectrometry. Analytical Chemistry 2003 75 10 2370 2376 2-s2.0-0037615160 10.1021/ac034033j (Pubitemid 36582821)
21. Aoyama K., Watabe M., Nakaki T., Regulation of neuronal glutathione synthesis. Journal of Pharmacological Sciences 2008 108 3 227 238 2-s2.0-56649105351 10.1254/jphs.08R01CR
22. Beal M. F., Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Annals of Neurology 1992 31 2 119 130 2-s2.0-0026584524
23. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J. K., Glutathione, iron and Parkinson's disease. Biochemical Pharmacology 2002 64 5-6 1037 1048 2-s2.0-0036710567 10.1016/S0006-2952(02)01174-7 (Pubitemid 35232279)
24. Jenner P., Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurologica Scandinavica, Supplement 1993 87 146 6 13 2-s2.0-0027185713 (Pubitemid 23251601)
25. Jha N., Jurma O., Lalli G., Liu Y., Pettus E. H., Greenamyre J. T., Liu R. M., Forman H. J., Andersen J. K., Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity: implications for Parkinson's disease. Journal of Biological Chemistry 2000 275 34 26096 26101 2-s2.0-0034714346 10.1074/jbc.M000120200
26. Arakawa M., Ito Y., N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 2007 6 4 308 314 2-s2.0-36549029828 10.1080/14734220601142878 (Pubitemid 350179062)
27. Arakawa M., Ushimaru N., Osada N., Oda T., Ishige K., Ito Y., N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neuroscience Research 2006 55 3 255 263 2-s2.0-33646764926 10.1016/j.neures.2006.03.008 (Pubitemid 43766414)
28. Munafo D. B., Colombo M. I., A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. Journal of Cell Science 2001 114 3619 3629 (Pubitemid 33041044)
29. Anantharam V., Kitazawa M., Wagner J., Kaul S., Kanthasamy A. G., Caspase-3-dependent proteolytic cleavage of protein kinase C δ is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. Journal of Neuroscience 2002 22 5 1738 1751 2-s2.0-0036523088 (Pubitemid 35386292)
30. Sun F., Kanthasamy A., Song C., Yang Y., Anantharam V., Kanthasamy A. G., Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKC δ proteolytic activation and mitochondrial translocation. Journal of Cellular and Molecular Medicine 2008 12 6 2467 2481 2-s2.0-57149125318 10.1111/j.1582-4934.2008.00293.x
31. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO Journal 2000 19 21 5720 5728 2-s2.0-0034329418
32. Fukami G., Hashimoto K., Koike K., Okamura N., Shimizu E., Iyo M., Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Research 2004 1016 1 90 95 2-s2.0-3042563295 10.1016/j.brainres.2004.04.072 (Pubitemid 38834276)
33. Zhang X., Banerjee A., Banks W. A., Ercal N., N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Research 2009 1275 87 95 2-s2.0-67349094895 10.1016/j.brainres.2009.04.008
34. Jayanthi S., Ladenheim B., Cadet J. L., Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Annals of the New York Academy of Sciences 1998 844 92 102 2-s2.0-0031818104 10.1111/j.1749-6632.1998.tb08224.x (Pubitemid 28367798)
35. LaVoie M. J., Hastings T. G., Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. Journal of Neuroscience 1999 19 4 1484 1491 2-s2.0-0033558324 (Pubitemid 29088929)
36. Jeng W., Wong A. W., Ting-A-Kee R., Wells P. G., Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radical Biology and Medicine 2005 39 3 317 326 2-s2.0-21344459220 10.1016/j. freeradbiomed.2005.03.015 (Pubitemid 40910188)
37. Ramirez S. H., Potula R., Fan S., Eidem T., Papugani A., Reichenbach N., Dykstra H., Weksler B. B., Romero I. A., Couraud P. O., Persidsky Y., Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. Journal of Cerebral Blood Flow and Metabolism 2009 29 12 1933 1945 2-s2.0-72049132918 10.1038/jcbfm.2009.112
38. Agarwal R., Shukla G. S., Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochemical Research 1999 24 12 1507 1514 2-s2.0-0032752658
39. Kannan K., Holcombe R. F., Jain S. K., Alvarez-Hernandez X., Chervenak R., Wolf R. E., Glass J., Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Molecular and Cellular Biochemistry 2000 205 1-2 53 66 2-s2.0-0033997054 (Pubitemid 30216788)
40. Marengo B., De Ciucis C., Verzola D., Pistoia V., Raffaghello L., Patriarca S., Balbis E., Traverso N., Cottalasso D., Pronzato M. A., Marinari U. M., Domenicotti C., Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma. Free Radical Biology and Medicine 2008 44 3 474 482 2-s2.0-38149034372 10.1016/j.freeradbiomed.2007.10.031
41. Armstrong J. S., Steinauer K. K., Hornung B., Irish J. M., Lecane P., Birrell G. W., Peehl D. M., Knox S. J., Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death and Differentiation 2002 9 3 252 263 2-s2.0-0036122504 10.1038/sj.cdd.4400959 (Pubitemid 34223869)
42. Flora G., Lee Y. W., Nath A., Maragos W., Hennig B., Toborek M., Methamphetamine-induced TNF- α gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. NeuroMolecular Medicine 2002 2 1 71 85 2-s2.0-0036362758 10.1385/NMM:2:1:71 (Pubitemid 37012511)
43. Açikgöz O., Gönenç S., Gezer S., Kayatekin B. M., Uysal N., Şemin I., Güre A., Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex. Neurotoxicity Research 2001 3 3 277 280 2-s2.0-0034793126 (Pubitemid 32962889)
44. Moszczynska A., Turenne S., Kish S. J., Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters 1998 255 1 49 52 2-s2.0-0032500860 10.1016/S0304-3940(98)00711-3 (Pubitemid 28494150)
45. Achat-Mendes C., Anderson K. L., Itzhak Y., Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 2007 32 3 531 541 2-s2.0-33847055889 10.1038/sj.npp.1301119
46. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K. S., Peretti F. J., Aiken S. S., Wickham D. J., Sherwin A., Nobrega J. N., Forman H. J., Kish S. J., Brain antioxidant systems in human methamphetamine users. Journal of Neurochemistry 2004 89 6 1396 1408 2-s2.0-3042611829 10.1111/j.1471-4159.2004. 02434.x (Pubitemid 38802661)
47. Itzhak Y., Ali S. F., The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. Journal of Neurochemistry 1996 67 4 1770 1773 2-s2.0-0029789902 (Pubitemid 26314238)
48. Fleckenstein A. E., Wilkins D. G., Gibb J. W., Hanson G. R., Interaction between hyperthermia and oxygen radical formation in the 5- hydroxytryptaminergic response to a single methamphetamine administration. Journal of Pharmacology and Experimental Therapeutics 1997 283 1 281 285 2-s2.0-0030771871 (Pubitemid 27438972)
49. Ali S. F., Itzhak Y., Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Annals of the New York Academy of Sciences 1998 844 122 130 2-s2.0-0031847891 10.1111/j.1749-6632.1998.tb08227.x (Pubitemid 28367801)
50. Açikgöz O., Gönenç S., Kayatekin B. M., Uysal N., Pekçetin Ç., Şemin I., Güre A., Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Research 1998 813 1 200 202 2-s2.0-0032583239 10.1016/S0006-8993(98)01020-8 (Pubitemid 29012537)
51. Deng X., Cadet J. L., Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Research 1999 851 1-2 254 257 2-s2.0-0033392081 10.1016/S0006-8993(99)02087-9 (Pubitemid 30038153)
52. Imam S. Z., Newport G. D., Islam F., Slikker W., Ali S. F., Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Research 1999 818 2 575 578 2-s2.0-0033550708 10.1016/S0006-8993(98)01311-0 (Pubitemid 29229979)
53. Bharath S., Andersen J. K., Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. Antioxidants and Redox Signaling 2005 7 7-8 900 910 2-s2.0-22044436635 10.1089/ars.2005.7.900 (Pubitemid 40967141)
54. Hsu M., Srinivas B., Kumar J., Subramanian R., Andersen J. K., Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. Journal of Neurochemistry 2005 92 5 1091 1103 2-s2.0-14644416354 10.1111/j.1471-4159.2004.02929.x (Pubitemid 40344300)
55. Gluck M. R., Moy L. Y., Jayatilleke E., Hogan K. A., Manzino L., Sonsalla P. K., Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. Journal of Neurochemistry 2001 79 1 152 160 2-s2.0-0034791072 10.1046/j.1471-4159.2001.00549.x (Pubitemid 32946652)
56. Park S. U., Ferrer J. V., Javitch J. A., Kuhn D. M., Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. Journal of Neuroscience 2002 22 11 4399 4405 2-s2.0-0036616838 (Pubitemid 37465656)
57. Moszczynska A., Yamamoto B. K., Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. Journal of Neurochemistry 2011 116 6 1005 1017 2-s2.0-79952453410 10.1111/j.1471-4159.2010. 07147.x
58. Dickinson D. A., Forman H. J., Cellular glutathione and thiols metabolism. Biochemical Pharmacology 2002 64 5-6 1019 1026 2-s2.0-0036709597 10.1016/S0006-2952(02)01172-3 (Pubitemid 35238033)
59. Dickinson D. A., Iles K. E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D. M., Forman H. J., 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radical Biology and Medicine 2002 33 7 974 987 2-s2.0-0036802703 10.1016/S0891-5849(02)00991-7 (Pubitemid 35284035)
60. Czubowicz K., Czapski G. A., Cieślik M., Strosznajder R. P., Lipoxygenase inhibitors protect brain cortex macromolecules against oxidation evoked by nitrosative stress. Folia Neuropathologica 2010 48 4 283 292 2-s2.0-78650461135
61. Latchoumycandane C., Anantharam V., Jin H., Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCdelta in cell culture and animal models of Parkinson's disease. Toxicology and Applied Pharmacology 2011 256 314 323
62. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V., Kanthasamy A. G., Caspase-3 dependent proteolytic activation of protein kinase C δ mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. European Journal of Neuroscience 2003 18 6 1387 1401 2-s2.0-0141705340 10.1046/j.1460-9568.2003.02864.x (Pubitemid 37215094)
63. Kaul S., Anantharam V., Yang Y., Choi C. J., Kanthasamy A., Kanthasamy A. G., Tyrosine phosphorylation regulates the proteolytic activation of protein kinase C δ in dopaminergic neuronal cells. Journal of Biological Chemistry 2005 280 31 28721 28730 2-s2.0-23344444562 10.1074/jbc.M501092200 (Pubitemid 41105773)
64. Iwashita A., Mihara K., Yamazaki S., Matsuura S., Ishida J., Yamamoto H., Hattori K., Matsuoka N., Mutoh S., A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)- 5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice. Journal of Pharmacology and Experimental Therapeutics 2004 310 3 1114 1124 2-s2.0-4243184854 10.1124/jpet.104.068932 (Pubitemid 39108933)
65. Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., Elazar Z., Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO Journal 2007 26 7 1749 1760 2-s2.0-34247186472 10.1038/sj.emboj.7601623 (Pubitemid 46624042)
66. Yuan H., Perry C. N., Huang C., Iwai-Kanai E., Carreira R. S., Glembotski C. C., Gottlieb R. A., LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American Journal of Physiology 2009 296 2 H470 H479 2-s2.0-61949346360 10.1152/ajpheart.01051.2008